P-10, r. 18.3 - Regulation respecting the prescription and interpretation of laboratory analyses by a pharmacist

Replaced on 25 January 2021

This document has official status.

chapter P-10, r. 18.3

Regulation respecting the prescription and interpretation of laboratory analyses by a pharmacist

Pharmacy Act

(chapter P-10, s. 10, 1st par., subpar. h).

Professional Code

(chapter C-26, s. 95).

Replaced, O.C. 1401-2020, 2020 G.O. 2, 3341A; eff. 2021-01-25; see chapter P-10, r. 3.2.

1. A pharmacist who practises in a centre operated by an institution within the meaning of the Act respecting health services and social services (chapter S-4.2) or within the meaning of the Act respecting health services and social services for Cree Native persons (chapter S-5) may prescribe and interpret laboratory analyses for the purpose of monitoring the drug therapy of a patient admitted to, registered or living in such a centre.

O.C. 603-2013, s. 1.

2. The pharmacist must be a member of the council of physicians, dentists and pharmacists of the institution that operates the centre.

O.C. 603-2013, s. 2.

3. The pharmacist must ensure in advance that no other laboratory analysis to the same effect is available.

O.C. 603-2013, s. 3.

4. The pharmacist must provide the follow-up required.

O.C. 603-2013, s. 4.

5. The pharmacist must enter in the patient’s record the reasons for which the pharmacist prescribes a laboratory analysis and the follow-up given.

O.C. 603-2013, s. 5.

6. (Omitted).

O.C. 603-2013, s. 6; S.Q. 2015, c. 8, s. 205.

REFERENCES

O.C. 603-2013, 2013 G.O. 2, 1510

S.Q. 2015, c. 8, s. 205